RDCRN 6501: Longitudinal study of Immune Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation
Study Status
Open to Enrollment
Study Description
This is a research study for men and women who have received or are preparing to receive a bone marrow, peripheral blood, or umbilical cord blood cell transplantation. After a transplant some people develop a disease called graft versus host disease (GVHD). GVHD occurs when the body’s immune system attacks itself, causing illness and potential harm.
The purpose of this study is to follow people after their transplant to better understand the onset and course of GVHD after stem cell transplant.
Participants will be in the study for at least 2 years after their transplant. There are 5 study visits; however, participants who get GVHD will have up to 7 additional visits.
Disease Status and/or Stage
Planned or Completed First Allogeneic Stem Cell Transplant
Sponsor
NIH, GVHD Consortium
Key Eligibility
- Planned or completed first allogeneic stem cell transplant (any conditioning regimen, graft source, donor type and GVHD prophylaxis regimen)
- Detailed eligibility reviewed when you contact the study team
Principal Investigator
Contact
- June Greenberg, RN
- (212) 746-2651
- [email protected]
- Bone Marrow Transplant Medical Practice
- (212) 746-2119
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Robert Hagerty
Subject Recruitment Manager
Tel: (646) 962-9340
[email protected]
